Parkinson's disease, L-Dopa and "express'' saccades: Superior colliculus dyskinesias?

被引：12
|
作者：
Cubizolle, Stephanie [1 ,2 ,3 ]
Damon-Perriere, Nathalie [2 ,4 ]
Dupouy, Sandrine [1 ,2 ]
Foubert-Samier, Alexandra [1 ,2 ,5 ]
Tison, Francois [1 ,2 ,3 ]
机构：
[1] CHU Bordeaux, Serv Neurol, F-330604 Pessac, France
[2] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33076 Bordeaux, France
[3] Univ Bordeaux 2, Neurophysiol Lab, CNRS, Inst Malad Neurodegenerat,UMR 5293, F-33076 Bordeaux, France
[4] CHU Bordeaux, F-33000 Bordeaux, France
[5] Univ Bordeaux, INSERM, ISPED, U897, F-33076 Bordeaux, France
来源：
CLINICAL NEUROPHYSIOLOGY | 2014年 / 125卷 / 03期
关键词：
PERFORMANCE;
D O I：
10.1016/j.clinph.2013.06.188
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：647 / 648
页数：2
相关论文
共 50 条
  • [21] L-dopa and dyskinesias in normal monkeys
    Pearce, RKB
    MOVEMENT DISORDERS, 1999, 14 : 9 - 12
  • [22] Molecular Effects of L-dopa Therapy in Parkinson's Disease
    Dorszewska, Jolanta
    Prendecki, Michal
    Lianeri, Margarita
    Kozubski, Wojciech
    CURRENT GENOMICS, 2014, 15 (01) : 11 - 17
  • [23] The evolution of the acute response to L-dopa in Parkinson's disease
    Hughes, AJ
    Lees, AJ
    MOVEMENT DISORDERS, 2002, 17 : S97 - S98
  • [24] L-Dopa plasma levels variability in Parkinson's disease
    Albani, G.
    Cattaldo, S.
    Mauro, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S118
  • [25] Effect of L-dopa on gastric motility in Parkinson's disease
    Albani, G.
    El Assawy, N.
    Cataldo, S.
    Mauro, A.
    JOURNAL OF NEUROLOGY, 2007, 254 : 64 - 65
  • [26] L-DOPA and cortical associative plasticity in Parkinson's disease
    Suppa, Antonio
    Bologna, Matteo
    Berardelli, Alfredo
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (04) : 638 - 639
  • [27] THE L-DOPA RESPONSE IN PATHOLOGICALLY CONFIRMED PARKINSON'S DISEASE
    Pitz, Vanessa
    Malek, Naveed
    Grosset, Katherine A.
    Grosset, Donald G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [28] Paradoxical response to L-dopa and apomorphine in the Parkinson's disease
    García-Soldevilla, MA
    Puertas, I
    Barcenilla, B
    Sayed, Y
    García-Albea, E
    Jiménez-Jiménez, FJ
    MOVEMENT DISORDERS, 2002, 17 : S96 - S96
  • [29] Parkinson's disease, L-DOPA, and endogenous morphine: A revisit
    Stefano, George B.
    Mantione, Kirk J.
    Kralickova, Milena
    Ptacek, Radek
    Kuzelova, Hana
    Esch, Tobias
    Kream, Richard M.
    MEDICAL SCIENCE MONITOR, 2012, 18 (08): : RA133 - RA137
  • [30] L-DOPA for Parkinson's disease-a bittersweet pill
    Lane, Emma L.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 384 - 398
12345